BACKGROUND: Plasma and serum levels of myeloperoxidase (MPO), a redox-active hemoprotein released by polymorphonuclear neutrophils (PMN) upon activation, is now recognized as a powerful prognostic determinant of myocardial infarction in patients suffering acute coronary syndromes. However, there is limited information on whether systemic MPO levels are also elevated and of discriminating value in patients with stable coronary artery disease (CAD) representing different ethnic groups. METHODS: Plasma levels of MPO and traditional CAD risk factors were quantified in African American and Caucasian patients (n=557) undergoing elective coronary angiography. RESULTS: MPO levels did not differ significantly between patients with or without CAD [421 pM (321, 533) vs. 412 pM (326, 500), p>0.05]. MPO levels were similar across ethnicity and gender, and correlated positively with CRP and fibrinogen levels (r=0.132, p=0.002 and r=0.106, p=0.011, respectively). CONCLUSION: In conclusion, plasma MPO levels were not elevated in patients with stable CAD, suggesting that systemic release of MPO is not a characteristic feature of asymptomatic CAD.
BACKGROUND: Plasma and serum levels of myeloperoxidase (MPO), a redox-active hemoprotein released by polymorphonuclear neutrophils (PMN) upon activation, is now recognized as a powerful prognostic determinant of myocardial infarction in patients suffering acute coronary syndromes. However, there is limited information on whether systemic MPO levels are also elevated and of discriminating value in patients with stable coronary artery disease (CAD) representing different ethnic groups. METHODS: Plasma levels of MPO and traditional CAD risk factors were quantified in African American and Caucasian patients (n=557) undergoing elective coronary angiography. RESULTS:MPO levels did not differ significantly between patients with or without CAD [421 pM (321, 533) vs. 412 pM (326, 500), p>0.05]. MPO levels were similar across ethnicity and gender, and correlated positively with CRP and fibrinogen levels (r=0.132, p=0.002 and r=0.106, p=0.011, respectively). CONCLUSION: In conclusion, plasma MPO levels were not elevated in patients with stable CAD, suggesting that systemic release of MPO is not a characteristic feature of asymptomatic CAD.
Authors: R Zhang; M L Brennan; X Fu; R J Aviles; G L Pearce; M S Penn; E J Topol; D L Sprecher; S L Hazen Journal: JAMA Date: 2001-11-07 Impact factor: 56.272
Authors: Carlos Rodriguez; Ariel Pablos-Méndez; Walter Palmas; Rafael Lantigua; Richard Mayeux; Lars Berglund Journal: Am J Cardiol Date: 2002-01-15 Impact factor: 2.778
Authors: A Hoy; D Trégouët; B Leininger-Muller; O Poirier; M Maurice; C Sass; G Siest; L Tiret; S Visvikis Journal: Eur J Hum Genet Date: 2001-10 Impact factor: 4.246
Authors: Furcy Paultre; Catherine H Tuck; Bernadette Boden-Albala; Douglas E Kargman; Elizabeth Todd; Jeffrey Jones; Myunghee C Paik; Ralph L Sacco; Lars Berglund Journal: Arterioscler Thromb Vasc Biol Date: 2002-01 Impact factor: 8.311
Authors: F Paultre; T A Pearson; H F Weil; C H Tuck; M Myerson; J Rubin; C K Francis; H F Marx; E F Philbin; R G Reed; L Berglund Journal: Arterioscler Thromb Vasc Biol Date: 2000-12 Impact factor: 8.311
Authors: Marijn C Meuwese; Mieke D Trip; Sanne van Wissen; Joram N I van Miert; John J P Kastelein; Erik S G Stroes Journal: Atherosclerosis Date: 2007-09-17 Impact factor: 5.162
Authors: Antonino Buffon; Luigi M Biasucci; Giovanna Liuzzo; Giuseppe D'Onofrio; Filippo Crea; Attilio Maseri Journal: N Engl J Med Date: 2002-07-04 Impact factor: 91.245
Authors: Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman Journal: Science Date: 2002-06-28 Impact factor: 47.728
Authors: Eraldo de Azevedo Lucio; Sandro C Gonçalves; Jorge P Ribeiro; Gilberto L Nunes; Jarbas R de Oliveira; Gustavo N Araujo; Marco V Wainstein Journal: Inflamm Res Date: 2010-09-17 Impact factor: 4.575
Authors: Htet W Khine; John F Teiber; Robert W Haley; Amit Khera; Colby R Ayers; Anand Rohatgi Journal: Atherosclerosis Date: 2017-06-03 Impact factor: 5.162
Authors: Anuradha Vivekanandan-Giri; Jessica L Slocum; Jaeman Byun; Chongren Tang; Robin L Sands; Brenda W Gillespie; Jay W Heinecke; Rajiv Saran; Mariana J Kaplan; Subramaniam Pennathur Journal: Ann Rheum Dis Date: 2013-01-12 Impact factor: 19.103
Authors: Carolyne K Smith; Anuradha Vivekanandan-Giri; Chongren Tang; Jason S Knight; Anna Mathew; Robin L Padilla; Brenda W Gillespie; Carmelo Carmona-Rivera; Xiaodan Liu; Venkataraman Subramanian; Sarfaraz Hasni; Paul R Thompson; Jay W Heinecke; Rajiv Saran; Subramaniam Pennathur; Mariana J Kaplan Journal: Arthritis Rheumatol Date: 2014-09 Impact factor: 10.995
Authors: Hubert Scharnagl; Marcus E Kleber; Bernd Genser; Sandra Kickmaier; Wilfried Renner; Gisela Weihrauch; Tanja Grammer; Christine Rossmann; Bernhard R Winkelmann; Bernhard O Boehm; Wolfgang Sattler; Winfried März; Ernst Malle Journal: Int J Cardiol Date: 2014-04-03 Impact factor: 4.164